Text Size

Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sjögren syndrome dry eye patients

Liang H., Kessal K., Rabut G., Daull P., Garrigue J.S., Melik Parsadaniantz S., Docquier M., Baudouin C., Brignole-Baudouin F.


  • 2019
  • Ocular Surface
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Affiliations

    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France; Quinze-Vingts National Ophthalmology Hospital, DHU Sight Restore, INSERM-DHOS CIC1423, Paris, France; Santen SAS, Evry, France; iGE3 Genomics Platform University of Geneva, Geneva, Switzerland; Université Versailles-Saint-Quentin-en-Yvelines, UVSQ, Hôpital Ambroise Paré, APHP, Boulogne-Billancourt, France; Université Sorbonne Paris Cité USPC, Université Paris Descartes, Faculté de Pharmacie de Paris, France

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022